Evidence map›Paper›PMID 36171158›Full record

ArticleDrug and alcohol dependence2022

Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada.

Soroush Moallef, Becky L Genberg, Kanna Hayashi, Shruti H Mehta, Gregory D Kirk, JinCheol Choi, Kora DeBeck, Michele Kipke, Richard D Moore, Marianna K Baum and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Socioeconomic inequities in drug poisoning deaths in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Soroush MoallefBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada.
Becky L GenbergDepartment of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kanna HayashiBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Shruti H MehtaDepartment of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Gregory D KirkDepartment of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
JinCheol ChoiBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada.
Kora DeBeckBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada; School of Public Policy, Simon Fraser University, Burnaby, BC, Canada.
Michele KipkeDivision of Research on Children, Youth, and Families, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Richard D MooreDivision of Infectious Diseases, John Hopkins University School of Medicine, Baltimore, MD, USA.
Marianna K BaumRobert Stempel College of Public Health, Florida International University, Miami, FL, USA.
Steven ShoptawDepartment of Family Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Pamina M GorbachDepartment of Epidemiology, Fielding School of Public Heath, University of California Los Angeles, Los Angeles, CA, USA.
Brian MustanskiInstitute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL, USA; Department of Medical Social Sciences, Northwestern University, Chicago, IL, USA.
Marjan JavanbakhtDepartment of Epidemiology, Fielding School of Public Heath, University of California Los Angeles, Los Angeles, CA, USA.
Susanne SiminskiFrontier Science Research Foundation, Amherst, NY, USA.
M-J MilloyBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: bccsu-mjm@bccsu.ubc.ca.
Johns Hopkins University · USSt. Paul's Hospital · CAUniversity of California, Los Angeles · USBritish Columbia Centre on Substance Use · CAChildren's Hospital of Los Angeles · USFlorida International University · USFrontier Science & Technology Research Foundation · USNorthwestern University · US

Funding

The RADAR cohort study of multilevel Influences on HIV and substance useU01DA036939 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Brian Mustanski, Michael E Newcomb · 2014 to 2026
$29.5M
The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
Young Men of Color Who Have Sex with Men Cohort StudyU01DA036926 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI GOLDBACH, JEREMY THOMAS, KIPKE, MICHELE D. · 2015 to 2024
$23.3M
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) U01DA036267 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SHOPTAW, STEVEN J · 2013 to 2024
$20.5M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular DiseaseU01DA040325 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LAI, SHENGHAN · 2016 to 2024
$12.7M
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable PopulationsU01DA040381 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI BAUM, MARIANNA K · 2015 to 2022
$9.6M
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Second Bridge Funding SupplementU24DA044554 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SIMINSKI, SUZANNE M. · 2017 to 2022
$6.8M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersU01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2017 to 2024
$4.3M
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United StatesR01DA053136 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GENBERG, BECKY LYNN · 2020 to 2024
$3.2M
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase IIU01MD017423 · NIMHD · FLORIDA INTERNATIONAL UNIVERSITY · PI BAUM, MARIANNA K · 2022 to 2023
$2.2M
NIDA NIH HHS R01 DA053136NIDA NIH HHS U01 DA021525NIDA NIH HHS U01 DA036267NIDA NIH HHS U01 DA036297NIDA NIH HHS U01 DA036926NIDA NIH HHS U01 DA036935NIDA NIH HHS U01 DA036939NIDA NIH HHS U01 DA038886NIDA NIH HHS U01 DA040325NIDA NIH HHS U01 DA040381NIDA NIH HHS U24 DA044554NIMHD NIH HHS U01 MD017423
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has compounded the longstanding drug poisoning crisis in Canada and the United States (US). Research is needed to understand the contributions of COVID-19 and subsequent infection control measures. We sought to estimate the prevalence of and factors associated with nonfatal overdose among participants in nine prospective cohorts of people who use unregulated drugs (PWUD) in Canada and the US.

methodsData were derived from nine cohorts of PWUD in urban centres in Canada (Vancouver, BC) and the US (Baltimore, MD; Miami, FL; Chicago, IL; Los Angeles, CA) between May, 2020 and April, 2021. Multivariable logistic regression was used to identify factors associated with nonfatal overdose among participants who used unregulated drugs in the past month.

resultsAmong 885 participants (including 253 females), 41 (4.6 %) experienced a non-fatal overdose in the past month, and 453 (51.2 %) reported being highly impacted day-to-day by the pandemic. In multivariable analyses, people who experienced a non-fatal overdose were more likely to be female (Adjusted Odds Ratio [AOR]=2.18;95 % Confidence Interval [CI]=1.10-4.30); unstably housed/homeless (AOR=2.16;95 % CI=1.11-4.26); engaged in medications for opioid use disorder (AOR=2.45;95 % CI=1.19-4.97); and highly impacted day-to-day (AOR=2.42;95 % CI=1.22-5.10).

conclusionOur findings may reflect characteristics of participants who experienced a compounding of vulnerabilities during the pandemic and thus are vulnerable to overdose, including women, those unstably housed/homeless, and those who perceived their daily lives were highly impacted by the pandemic. Multi-level interventions are needed to remediate the vulnerabilities and address the main driver of poisoning crisis.

Indexed as

COVID-19Drug OverdoseOpioid-Related DisordersCanadaFemaleHumansMalePandemicsProspective StudiesUnited StatesAddictionCOVID-19 pandemicDrug OverdoseHarm ReductionPeople who use drugsPublic Health

Identifiers

PMID36171158
PMCPMC9476331
OpenAlexW4295958759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.